Cross Country Healthcare Announces Fourth Quarter and Full Year 2025 Financial Results

About this update from Cross Country Healthcare, Inc.

[{"type":"text","content":" BOCA RATON, Fla.--(BUSINESS WIRE)--\nCross Country Healthcare, Inc. (the “Company,” “Cross Country,” “we,” “us,” and “our”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2025.\n\n\n\n\nSELECTED FINANCIAL INFORMATION:\n\n\n\n\n\n\n\nDollars are in thousands, except per share amounts\n\nQ4 2025\n\n\n\n\n\n\nVariance\nQ4 2025 vs\nQ4 2024\n\n\n\n\n\n\nVariance\nQ4 2025 vs\nQ3 2025\n\n\n\n\n\n\nFull Year 2025\n\n\n\n\n\n\nVariance\n2025 vs\n2024\n\n\n\n\n\n\n\n\nRevenue\n\n\n\n\n\n\n$\n\n\n\n\n\n\n236,761\n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n(24\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n \n\n\n\n\n\n\n(5\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n$\n\n\n\n\n\n\n1,054,293\n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n(22\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n\n\nGross profit margin*\n\n\n\n\n\n\n \n\n\n\n\n\n\n20.3\n\n\n\n\n\n\n \n\n\n\n\n\n\n%\n\n\n\n\n\n\n \n\n\n\n\n\n\n30\n\n\n\n\n\n\n \n\n\n\n\n\n\nbps\n\n\n\n\n\n\n \n\n\n\n\n\n\n(10\n\n\n\n\n\n\n)\n\n\n\n\n\n\nbps\n\n\n\n\n\n\n \n\n\n\n\n\n\n20.3\n\n\n\n\n\n\n \n\n\n\n\n\n\n%\n\n\n\n\n\n\n \n\n\n\n\n\n\n(10\n\n\n\n\n\n\n)\n\n\n\n\n\n\nbps\n\n\n\n\n\n\n\n\nNet loss attributable to common stockholders\n\n\n\n\n\n\n$\n\n\n\n\n\n\n(82,929\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n(2,110\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n \n\n\n\n\n\n\n(1,637\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n$\n\n\n\n\n\n\n(94,852\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n(552\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n\n\nDiluted EPS\n\n\n\n\n\n\n$\n\n\n\n\n\n\n(2.56\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n$\n\n\n\n\n\n\n(2.44\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n$\n\n\n\n\n\n\n(2.41\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n$\n\n\n\n\n\n\n(2.93\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n$\n\n\n\n\n\n\n(2.49\n\n\n\n\n\n\n)\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\nAdjusted EBITDA*\n\n\n\n\n\n\n$\n\n\n\n\n\n\n4,067\n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n(56\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n \n\n\n\n\n\n\n(38\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n$\n\n\n\n\n\n\n26,801\n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n \n\n\n\n\n\n\n(45\n\n\n\n\n\n\n)\n\n\n\n\n\n\n%\n\n\n\n\n\n\n\n\nAdjusted EBITDA margin*\n\n\n\n\n\n\n \n\n\n\n\n\n\n1.7\n\n\n\n\...

More updates from Cross Country Healthcare, Inc.